Dyskinesia, Drug-Induced

Explore clinical trials studying Dyskinesia, Drug-Induced. Study availability and eligibility vary by location and protocol.

5 public trials 1 recruiting study

Refine in advanced search Browse all conditions

Dyskinesia, Drug-Induced trial results

Recruiting

NCT06570824

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +18 more
Locations: DRCMR Hvidovre, Denmark

Completed

NCT04064294

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +15 more
Locations: VA Portland Health Care System, Portland, OR Portland, Oregon, United States

Oregon Health & Science University Portland, Oregon, United States

VA Puget Sound Health Care System Seattle Division, Seattle, WA Seattle, Washington, United States

Completed

NCT01173731

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +16 more
Locations: Novartis Investigative Site Sunnyvale, California, United States

Novartis Investigative Site Englewood, Colorado, United States

Novartis Investigative Site Indianapolis, Indiana, United States

Novartis Investigative Site Heidelberg, Victoria, Australia

View all 22 locations

Completed

NCT03354455

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +15 more
Locations: Danish Research Centre for Magnetic Resonance Hvidovre, Capital Region, Denmark

Completed

NCT00255879

Conditions: Central Nervous System Diseases, Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, +13 more
Locations: University of California, San Diego Division of Geriatric Psychiatry San Diego, California, United States